Skip to main content
SpringerLink
Log in

Giant duodenal ulcer

Evaluation of basal acid output, nonsteroidal antiinflammatory drug use, and ulcer complications

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Patients with giant duodenal ulcer (>2 cm) have more ulcer complications (ie, bleeding) than patients with duodenal ulcer in the standard range (0.5–1.5 cm). To evaluate possible differences between patients with giant duodenal ulcer and those with duodenal ulcer in the standard range, we determined basal acid outputs by nasogastric suction, percentage of patients with daily nonsteroidal antiinflammatory drug (NSAID) use, and percentage of ulcer complications in 184 patients with endoscopically documented active duodenal ulcer. Seventeen patients had giant duodenal ulcer, and 167 patients had duodenal ulcer in the standard range. The mean basal acid outputs for the 17 patients with giant duodenal ulcer was 7.9 meq/hr (range 0.0–27.8 meq/hr) and for the 167 patients with duodenal ulcer in the standard range was 9.0 meq/hr (range 0.0–49.1 meq/hr), which were not significantly different. There was a significant difference in the percentages of ulcer complications between the 17 patients with giant duodenal ulcer and the 167 patients with duodenal ulcer in the standard range: 65% compared to 25% (P=0.001), and in the percentages of patients with regular daily NSAID use, during the one month preceding the upper gastrointestinal endoscopy: 53% compared to 8% (P=0.00001). However, a significant association between NSAID use and duodenal ulcer complication was not apparent. These results suggest that the development of giant duodenal ulcer and the significant increase in complications associated with giant duodenal ulcer are not attributable to increased basal acid output, however, they may be attributable to increased NSAID use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Klamer TW, Mahr MM: Giant duodenal ulcer: A dangerous variant of a common illness. Am J Surg 135:760–762, 1978

    PubMed  Google Scholar 

  2. Nussbaum MS, Schusterman MA: Management of giant duodenal ulcer. Am J Surg 149:357–361, 1985

    PubMed  Google Scholar 

  3. Bianchi-Porro G, Lazzaroni M, Petrillo M: Giant duodenal ulcers. Dig Dis Sci 29:781, 1984 (letter)

    Google Scholar 

  4. Gustavsson S, Kelly KA, Hench VS, Melton LJ: Giant gastric and duodenal ulcers: A population-based study with a comparison to nongiant ulcers. World J Surg 31:333–338, 1987

    Google Scholar 

  5. Cranford CA, Olson R, Bradley EL: Gastric disconnection in the management of perforated giant duodenal ulcer. Am J Surg 155:439–442, 1988

    PubMed  Google Scholar 

  6. Collen MJ, Kalloo AN, Sheridan MJ: Bleeding duodenal ulcer: Role of gastric acid hypersecretion. Dig Dis Sci 38:269–275, 1993

    PubMed  Google Scholar 

  7. Armstrong CP, Blower AL: Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 28:527–532, 1987

    PubMed  Google Scholar 

  8. Collier D St J, Pain JA: Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 26:359–363, 1985

    PubMed  Google Scholar 

  9. Soll AH, Weinstein WM, Kurata J, McCarthy D: Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 114:307–319, 1991

    PubMed  Google Scholar 

  10. Morrow CE, Mulholland MW, Dunn DH, Schwartz ML, Sutherland DER, Goodlae RL, Humphrey E, Najarian JS: Giant duodenal ulcer. Am J Surg 144:330–331, 1982

    PubMed  Google Scholar 

  11. Mistilis SP, Wiot JF, Nedelman SH: Giant duodenal ulcer. Ann Intern Med 59:156–164, 1963

    Google Scholar 

  12. Raufman J-P, Collins SM, Korman LY, Pandol SJ, Collen MJ, Cornelius MJ, Feld MK, McCarthy DM, Gardner JD, Jensen RT: Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome. Gastroenterology 84:108–113, 1983

    PubMed  Google Scholar 

  13. Collen MJ, Sheridan MJ: Definition for idiopathic gastric acid hypersecretion: A statistical and functional evaluation. Dig Dis Sci 36:1371–1376, 1991

    PubMed  Google Scholar 

  14. Frucht H, Howard JM, Slaff JI, Wank SA, McCarthy DM, Maton PN, Vinayek R, Gardner JD, Jensen RT: Secretin and calcium provocative tests in the Zollinger-Ellison syndrome: A prospective study. Ann Intern Med 111:713–722, 1989

    PubMed  Google Scholar 

  15. Cochran WG, Snedecor GW: Statistical Methods, 7th ed. Ames, Iowa, Iowa State University Press, 1980

    Google Scholar 

  16. Richardson CT: Role of aggressive factors in the pathogenesis of peptic ulcer disease. Scand J Gastroenterol 25(suppl 174):37–43, 1990

    Google Scholar 

  17. Kaye MD, Rhodes J, Beck P: Gastric secretion in duodenal ulcer with particular reference to the diagnosis of Zollinger-Ellison syndrome. Gastroenterology 58:476–481, 1970

    PubMed  Google Scholar 

  18. Grossman MI, Kirsner JB, Gillespie IE: Basal and histalog stimulated gastric secretion in control subjects and in patients with peptic ulcer or gastric cancer. Gastroenterology 45:14–26, 1963

    PubMed  Google Scholar 

  19. Baron JH: An assessment of the augmented histamine test in the diagnosis of peptic ulcer: Correlations between gastric secretion, age and sex of patients, and site and nature of the ulcer. Gut 4:243–253, 1963

    Google Scholar 

  20. Hirschowitz BI: Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer. Gastroenterology 86:843–851, 1984

    PubMed  Google Scholar 

  21. Bergegardh S, Broman G, Knutson U, Palmer L, Olbe L: Gastric acid responses to graded i.v. infusion of pentagastrin and histalog in peptic ulcer patients before and after antrumbulb resection. Scand J Gastroenterol 11:337–346, 1976

    PubMed  Google Scholar 

  22. Sasaki H, Nagulesparan M, Samloff IM, Straus E, Sievers ML, Dubois A: Low acid output in Pima Indians: A possible cause for the rarity of duodenal ulcer in this population. Dig Dis Sci 29:785–789, 1984

    PubMed  Google Scholar 

  23. Breuer RI, Kirsner JB: Present status of histalog gastric analysis in man. Ann NY Acad Sci 140:882–895, 1967

    PubMed  Google Scholar 

  24. Moore JG, Halberg F: Circadian rhythm of gastric acid secretion in men with active duodenal ulcer. Dig Dis Sci 31:1185–1191, 1986

    PubMed  Google Scholar 

  25. Marks IN, Bank S, Moshal MG, Louw JH: The augmented histamine test. A review of 615 cases of gastroduodenal disease. S Afr J Surg 1:53–59, 1963

    Google Scholar 

  26. Faber RG, Hobsley M: Basal gastric secretion: Reproducibility and relationship with duodenal ulceration. Gut 18:57–63, 1977

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Division of Gastroenterology, Department of Medicine, Loma Linda University Medical Center, Loma Linda, California

    Martin J. Collen MD, Michael J. Santoro MD & Yang K. Chen MD

Authors
  1. Martin J. Collen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Santoro MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yang K. Chen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Collen, M.J., Santoro, M.J. & Chen, Y.K. Giant duodenal ulcer. Digest Dis Sci 39, 1113–1116 (1994). https://doi.org/10.1007/BF02087566

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02087566

Key words

Search

Navigation